Keystone is internationally recognized as a top ophthalmic clinical research organization. For the past 3 decades, Keystone is a leading investigational site for virtually every participating clinical trial piloting to FDA approval of sight saving ophthalmic drugs and devices. 

 Our vast experience in conducting all phases of clinical trials for devices and pharmaceuticals positions us to be both efficient and effective. These are just a few of the areas we have participated in changing the course of ophthalmology for the better: